Implementation of Risk-reducing Strategies for Breast Cancer is Long Overdue

Area of Science:

• Oncology
• Preventive Medicine
• Pharmacology

Background:

• Chemoprevention is a proven strategy for reducing breast cancer risk.
• Despite strong evidence and recommendations, uptake of chemoprevention remains low in eligible women.
• Barriers include fear of adverse effects, cost, and inadequate risk assessment tools.

Purpose of the Study:

• To highlight the persistent challenge of underutilization of breast cancer chemoprevention.
• To discuss strategies for improving the adoption and utilization of risk-reducing medications.
• To address the need for better risk assessment and benefit-harm thresholds.

Main Methods:

• Review of existing evidence on chemoprevention efficacy and barriers.
• Analysis of clinical challenges in implementing risk-reducing strategies.
• Discussion of potential solutions and recommendations for improving uptake.

Main Results:

• Chemoprevention for breast cancer is underused globally.
• Key barriers identified are fear of side effects, medication costs, and poor risk assessment.
• Effective strategies are suggested to enhance the utilization of safe chemoprevention agents.

Conclusions:

• Improving breast cancer risk reduction requires addressing patient and clinician barriers to chemoprevention.
• Enhanced risk assessment tools and clear benefit-harm thresholds are crucial.
• Implementing targeted strategies can increase the uptake of effective chemoprevention medications.